Figure 1.

Comparison of mean visual acuity in logarithm of the minimum angle of resolution (logMAR) units between eyes treated with pneumatic displacement (PD) only or PD combined with intravitreal bevacizumab (PD + IVB). The difference in visual acuity between the two groups at baseline was not significant (P=0.59). However, the differences between the two groups at 1, 3, and 6 months after treatment were significant (P<0.01, P<0.01, and P<0.01, respectively).

Abbreviations: IVB, intravitreal bevacizumab; PD, pneumatic displacement; VA, visual acuity; M, month.